新闻
2 小时之前
Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)
ASCO会议临床研究
2 小时之前
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
快速通道多肽偶联药物ASCO会议
5 小时之前
临床研究
5 小时之前
Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial
细胞疗法ASCO会议免疫疗法
2023-06-02
康方生物PCSK9单抗上市申请获受理
抗体药物偶联物申请上市
2023-06-02
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
临床结果免疫疗法快速通道
2023-06-02
靶向PCSK9!圣因生物首款siRNA药物在澳大利亚启动临床试验
siRNA临床申请核酸药物
2023-06-02
北海康成引进的IBAT抑制剂国内获批
上市批准临床3期临床结果
2023-06-02
IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
临床申请临床结果免疫疗法临床2期
2023-06-02
Coherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023
上市批准免疫疗法